Ovid Therapeutics
OVID
OVID
74 hedge funds and large institutions have $35.4M invested in Ovid Therapeutics in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
77% less capital invested
Capital invested by funds: $153M → $35.4M (-$117M)
Holders
74
Holding in Top 10
1
Calls
$23K
Puts
$8K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$1.08M | |
| 3 | +$334K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$237K |
| 5 |
State Street
Boston,
Massachusetts
|
+$153K |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$2.64M | |
| 3 | -$449K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$349K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$257K |